Neuroya

Company Overview

Snapshot

Founded in February 2017 by Moshe Daninos, Neuroya operated with 1–10 employees. The company raised $50,000 across one funding round. Neuroya ceased operations in December 2020.

Business overview

Neuroya developed a brain-computer interface designed to optimize the diagnosis and management of common neuropathologies such as attention deficit hyperactivity disorder, stroke, and autism. The company's platform translates observations and understanding of the nervous system to manipulate behavior-related neural processes, aiming to restore or enhance functions. Based on continuous data collection, its algorithm suggests personalized treatments and analysis, including real-time representation of brain activity through smart devices. Neuroya operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Medical Devices.

Company Intelligence Q&A

What is Neuroya's primary focus?

Neuroya focuses on developing a brain-computer interface to optimize the diagnosis and management of common neuropathologies, including attention deficit hyperactivity disorder, stroke, and autism.

When was Neuroya founded?

Neuroya was founded in February 2017.

Who is a founder of Neuroya?

Moshe Daninos is a founder of Neuroya.

What is the status of Neuroya?

Neuroya is non-active, having ceased operations in December 2020.

What was Neuroya's total disclosed capital raised?

Neuroya raised a total of $50,000 across one funding round.